Literature DB >> 1415451

Ocular hydrofluoric acid burns.

R S Rubinfeld1, D I Silbert, J J Arentsen, P R Laibson.   

Abstract

A 30-year-old man sustained exposure of his eyes, face, and neck involving 4% of body surface area to hydrofluoric acid. He was treated with immediate lavage and topical calcium gluconate. Because free fluoride ions from ocular and facial exposures can form complexes with body stores of calcium and magnesium, the patient was transferred to a burn unit for cardiac and electrolyte monitoring. He was also treated with calcium gluconate skin injections, pulmonary nebulizer therapy, and topical antibiotics and corticosteroids. In another case, a 25-year-old man with less severe exposure to hydrofluoric acid was treated as an outpatient with topical antibiotics, corticosteroids, and cycloplegia. If an ophthalmologist is the first to treat a patient with chemical exposure, the history of hydrofluoric acid exposure must be obtained, and the burn team and other medical specialists must be quickly consulted to avoid potentially fatal complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415451     DOI: 10.1016/s0002-9394(14)71852-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  Possible hazardous effects of hydrofluoric acid and recommendations for treatment approach: a review.

Authors:  Mutlu Ozcan; Arezo Allahbeickaraghi; Mine Dündar
Journal:  Clin Oral Investig       Date:  2011-11-09       Impact factor: 3.573

2.  Comparison of skin effects of immediate treatment modalities in experimentally induced hydrofluoric acid skin burns.

Authors:  Meltem K Songur; Ovunc Akdemir; William C Lineaweaver; Turker Cavusoglu; Murat Ozsarac; Huseyin Aktug; Ecmel Songur; Yigit O Tiftikcioglu
Journal:  Int Wound J       Date:  2014-01-29       Impact factor: 3.315

3.  Treatment of hydrofluoric acid exposure to the eye.

Authors:  Katherine Atley; Edward Ridyard
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.